Parallel Advisors, LLC Sesen Bio, Inc. Transaction History

Parallel Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$0.73 - $1.28 $547 - $960	-750 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$0.77 - $4.91 $423 - $2,700	-550 Reduced 42.31%	750 $1,000
Q2 2021 Aug 06, 2021	SELL	$2.18 - $4.66 $2,616 - $5,592	-1,200 Reduced 48.0%	1,300 $6,000
Q1 2021 Apr 23, 2021	SELL	$1.3 - $3.24 $2,340 - $5,832	-1,800 Reduced 41.86%	2,500 $7,000
Q4 2020 Feb 02, 2021	SELL	$1.01 - $1.77 $418 - $732	-414 Reduced 8.78%	4,300 $6,000
Q3 2020 Oct 27, 2020	BUY	$0.67 - $1.4 $1,148 - $2,399	1,714 Added 57.13%	4,714 $7,000
Q1 2020 Apr 27, 2020	BUY	$0.39 - $1.03 $195 - $515	500 Added 20.0%	3,000 $1,000
Q4 2019 Jan 30, 2020	BUY	$0.89 - $1.5 $2,225 - $3,750	2,500 New	2,500 $3,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.